The nuclear pore complex protein RANBP2 has emerged as a critical factor in the development and progression of various solid malignancies.

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...